Invention Application
- Patent Title: DIHYDROOROTATE DEHYDROGENASE INHIBITORS
-
Application No.: US17742606Application Date: 2022-05-12
-
Publication No.: US20220298137A1Publication Date: 2022-09-22
- Inventor: Scott Kuduk , Zhuming Zhang , Lindsey DeRatt , Aihua Wang
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D417/14 ; C07D471/04
Abstract:
Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.
Public/Granted literature
- US11753393B2 Dihydroorotate dehydrogenase inhibitors Public/Granted day:2023-09-12
Information query
